P French1, N Shryane, R P Bentall, S W Lewis, A P Morrison. 1. Psychology Services, Bolton Salford & Trafford Mental Health Trust, School of Psychological Sciences, The University of Manchester, Early Intervention Service, BSTMHT, Bury New Road, Prestwich, Manchester M25 3BL, UK. paul.french@bstmht.nhs.uk
Abstract
BACKGROUND: There have been recent advances in the identification of people at high risk of psychosis and psychological treatments have shown promise for prevention. AIMS: To compare the longitudinal course of psychotic experiences and emotional dysfunction in high-risk participants receiving cognitive therapy with those receiving treatment as usual. METHOD: Data from a recent randomised controlled trial of cognitive therapy for people at risk of developing psychosis were utilised to examine three different statistical models that were based on 432 measurements of psychotic experiences and 421 of emotional dysfunction (anxiety-depression) contributed by 57 participants across the 13 measurement occasions (monthly monitoring for a year). RESULTS:Psychotic experiences and emotional dysfunction were correlated and decreased significantly over the course of the study, with most improvement in the early months. The reduction in positive symptoms, but not emotional dysfunction, was enhanced by allocation to cognitive therapy. CONCLUSIONS:Psychotic experiences and emotional dysfunction appear to interact in people at risk of developing psychosis. There appears to be a specific benefit of cognitive therapy.
RCT Entities:
BACKGROUND: There have been recent advances in the identification of people at high risk of psychosis and psychological treatments have shown promise for prevention. AIMS: To compare the longitudinal course of psychotic experiences and emotional dysfunction in high-risk participants receiving cognitive therapy with those receiving treatment as usual. METHOD: Data from a recent randomised controlled trial of cognitive therapy for people at risk of developing psychosis were utilised to examine three different statistical models that were based on 432 measurements of psychotic experiences and 421 of emotional dysfunction (anxiety-depression) contributed by 57 participants across the 13 measurement occasions (monthly monitoring for a year). RESULTS:Psychotic experiences and emotional dysfunction were correlated and decreased significantly over the course of the study, with most improvement in the early months. The reduction in positive symptoms, but not emotional dysfunction, was enhanced by allocation to cognitive therapy. CONCLUSIONS:Psychotic experiences and emotional dysfunction appear to interact in people at risk of developing psychosis. There appears to be a specific benefit of cognitive therapy.
Authors: Dina Collip; Johanna T W Wigman; Ashleigh Lin; Barnaby Nelson; Margreet Oorschot; Wilma A M Vollebergh; Jaymee Ryan; Gennedy Baksheev; Marieke Wichers; Jim van Os; Inez Myin-Germeys; Alison R Yung Journal: Schizophr Bull Date: 2011-09-19 Impact factor: 9.306
Authors: Sibel Algon; James Yi; Monica E Calkins; Christian Kohler; Karin E Borgmann-Winter Journal: Curr Psychiatry Rep Date: 2012-04 Impact factor: 5.285
Authors: Elaine F Walker; Barbara A Cornblatt; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Scott W Woods; Robert Heinssen Journal: Schizophr Res Date: 2009-08-25 Impact factor: 4.939
Authors: Emma Soneson; Debra Russo; Clare Knight; Louise Lafortune; Margaret Heslin; Jan Stochl; Alex Georgiadis; Julieta Galante; Robbie Duschinsky; Nick Grey; Leticia Gonzalez-Blanco; Juliet Couche; Michelle Griffiths; Hannah Murray; Nesta Reeve; Joanne Hodgekins; Paul French; David Fowler; Sarah Byford; Mary Dixon-Woods; Peter B Jones; Jesus Perez Journal: Syst Rev Date: 2019-05-23